Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 75, Issue 1, Pages 16-29Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jo9013832
Keywords
-
Categories
Funding
- NIH [CA109164, 1S10RR023444, 1S10RR022442]
- NSF [CHE-0911713]
- 3D Pharmaceuticals
- Novartis Division of Organic Chemistry of the American Chemical Society
- Direct For Mathematical & Physical Scien [0911713] Funding Source: National Science Foundation
- NATIONAL CANCER INSTITUTE [R56CA109164, R01CA109164] Funding Source: NIH RePORTER
- NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022442, S10RR023444] Funding Source: NIH RePORTER
Ask authors/readers for more resources
An enantioselective approach to the perylenequinone core found in the mold perylenequinone natural products is outlined. Specifically, the first asymmetric syntheses of helical chiral perylenequinones absent any additional stereogenic centers are described. Key elements of the synthetic venture include a catalytic enantioselective biaryl coupling, a PIFA-induced naphthalene hydroxylation, and a palladium-mediated aromatic decarboxylation. Transfer of the binaphthalene axial stereochemistry to the perylenequinone helical stereochemistry proceeded with good fidelity. Furthermore, the resultant perylenequinones were shown to possess Sufficient atropisomeric stability to be viable intermediates in the biogenesis of the perylenequinone natural products. This stability supports the use of the helical axis as a stereochemical relay in synthesis of the natural products containing additional stereochemical centers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available